Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 9Active not recruiting 6Not yet recruiting 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Breast Neoplasms 159Neoplasms 116Carcinoma, Non-Small-Cell Lung 91Colorectal Neoplasms 86Prostatic Neoplasms 85Lung Neoplasms 78Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 52Pancreatic Neoplasms 46Neoplasm Metastasis 44Multiple Myeloma 38Recurrence 35Triple Negative Breast Neoplasms 31Squamous Cell Carcinoma of Head and Neck 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Ovarian Neoplasms 29Melanoma 28Uterine Cervical Neoplasms 27Stomach Neoplasms 27Glioblastoma 27Brain Neoplasms 27Rectal Neoplasms 25Head and Neck Neoplasms 25Small Cell Lung Carcinoma 23Carcinoma, Renal Cell 23Endometrial Neoplasms 20Lymphoma, B-Cell 19Glioma 19Sarcoma 18Lymphoma, Follicular 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Myeloid, Chronic-Phase × 90 days × Clear all
NCT07454850 2026-05-18

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

Novartis

Not yet recruiting
400 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT07489755 2026-03-24

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

Shenzhen TargetRx Co., Ltd.

Phase 3 Not yet recruiting
180 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡